These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 18204414)
21. Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis. Krinsky-McHale SJ; Silverman W Dev Disabil Res Rev; 2013; 18(1):31-42. PubMed ID: 23949827 [TBL] [Abstract][Full Text] [Related]
22. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. Mitchell AJ J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):966-75. PubMed ID: 19465413 [TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias. Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593 [TBL] [Abstract][Full Text] [Related]
24. Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Whitwell JL; Petersen RC; Negash S; Weigand SD; Kantarci K; Ivnik RJ; Knopman DS; Boeve BF; Smith GE; Jack CR Arch Neurol; 2007 Aug; 64(8):1130-8. PubMed ID: 17698703 [TBL] [Abstract][Full Text] [Related]
26. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. Monastero R; Mangialasche F; Camarda C; Ercolani S; Camarda R J Alzheimers Dis; 2009; 18(1):11-30. PubMed ID: 19542627 [TBL] [Abstract][Full Text] [Related]
27. [Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy]. Kurz A; Diehl J; Riemenschneider M; Perneczky R; Lautenschlager N Nervenarzt; 2004 Jan; 75(1):6-15. PubMed ID: 14722656 [TBL] [Abstract][Full Text] [Related]
28. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers. Dukart J; Sambataro F; Bertolino A J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054 [TBL] [Abstract][Full Text] [Related]
29. A critical discussion of the role of neuroimaging in mild cognitive impairment. Wolf H; Jelic V; Gertz HJ; Nordberg A; Julin P; Wahlund LO Acta Neurol Scand Suppl; 2003; 179():52-76. PubMed ID: 12603252 [TBL] [Abstract][Full Text] [Related]
30. [Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors]. Defranceso M; Schocke M; Messner HJ; Deisenhammer EA; Hinterhuber H; Marksteiner J; Weiss EM Neuropsychiatr; 2010; 24(2):88-98. PubMed ID: 20605004 [TBL] [Abstract][Full Text] [Related]
31. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
32. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458 [TBL] [Abstract][Full Text] [Related]
33. Frontotemporal mild cognitive impairment. de Mendonça A; Ribeiro F; Guerreiro M; Garcia C J Alzheimers Dis; 2004 Feb; 6(1):1-9. PubMed ID: 15004322 [TBL] [Abstract][Full Text] [Related]
36. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
37. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618 [TBL] [Abstract][Full Text] [Related]
38. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749 [TBL] [Abstract][Full Text] [Related]
40. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment. Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]